Digital ulcers in systemic sclerosis: role of flow-mediated dilatation and capillaroscopy as risk assessment tools

Eur J Dermatol. 2015 Sep-Oct;25(5):444-51. doi: 10.1684/ejd.2015.2605.

Abstract

Aim: The aim of this study was to evaluate macrovascular endothelial dysfunction and microvascular damage as clinical markers of peripheral microangiopathy in patients with Raynaud's phenomenon (RP).

Patients and methods: Seventy-seven secondary RP with systemic sclerosis, 32 primary RP and 34 healthy controls were included in our study. Secondary RP patients were divided into two subgroups: 39 with digital ulcers (DU) and 38 without digital ulcers (non-DU).

Results: Patients with DU had significantly lower flow-mediated dilatation values (5.34 ± 7.49%) compared to non-DU patients (16.21 ± 11.31%), primary RP (17.96 ± 12.78%) and controls (20.17 ± 8.86%), p<0.001, favouring macrovascular endothelium dysfunction. Regarding microvascular damage, the DU group had a predominately capillaroscopic late pattern (71.1%) whereas non-DU patients had an active pattern (56.4%). The microangiopathy evolution score was significantly higher in the DU group compared to the non-DU group (4.79 ± 1.82 vs. 1.79 ± 1.56, p<0.001). Flow-mediated dilation was significantly lower in late pattern (6.13 ± 7.09%) compared to active (12.58 ± 10.66%) and early patterns (17.72 ± 14.90%), p = 0.016 and p = 0.044 respectively.

Conclusions: Low flow-mediated dilatation and microvascular damage in capillaroscopy are early clinical markers of DU risk in RP patients.

Keywords: Raynaud's phenomenon; capillaroscopy; digital ulcer; endothelial dysfunction; flow-mediated dilatation; systemic sclerosis.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Blood Flow Velocity
  • Case-Control Studies
  • Comorbidity
  • Female
  • Fingers
  • Humans
  • Male
  • Microscopic Angioscopy
  • Middle Aged
  • Raynaud Disease / diagnosis
  • Raynaud Disease / epidemiology*
  • Reference Values
  • Risk Assessment
  • Role
  • Scleroderma, Systemic / diagnosis
  • Scleroderma, Systemic / epidemiology*
  • Severity of Illness Index
  • Skin / blood supply*
  • Skin Ulcer / drug therapy
  • Skin Ulcer / physiopathology*
  • Ultrasonography, Interventional
  • Vasodilation / physiology